RxSight, Inc. (RXST)
Largest Insider Buys in Sector
RXST Stock Price History Chart
RXST Stock Performance
About RxSight, Inc.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction …
Insider Activity of RxSight, Inc.
Over the last 12 months, insiders at RxSight, Inc. have bought $712,129 and sold $59.22M worth of RxSight, Inc. stock.
On average, over the past 5 years, insiders at RxSight, Inc. have bought $5.58M and sold $30.9M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Tammenoms Bakker Juliet (director) — $1.42M.
The last purchase of 5,000 shares for transaction amount of $305,457 was made by Tammenoms Bakker Juliet (director) on 2024‑05‑17.
List of Insider Buy and Sell Transactions, RxSight, Inc.
| 2024-11-04 | Sale | See remarks | 3,100 0.0077% | $51.05 | $158,247 | +6.79% | ||
| 2024-10-30 | Sale | See remarks | 3,105 0.0079% | $51.91 | $161,171 | -0.07% | ||
| 2024-10-28 | Sale | See remarks | 3,100 0.0079% | $50.64 | $156,993 | +3.00% | ||
| 2024-10-25 | Sale | See remarks | 3,100 0.0077% | $49.79 | $154,360 | 0.00% | ||
| 2024-10-22 | Sale | See remarks | 3,100 0.0077% | $49.68 | $154,001 | 0.00% | ||
| 2024-10-18 | Sale | See remarks | 3,105 0.0078% | $50.09 | $155,533 | +1.47% | ||
| 2024-10-16 | Sale | See remarks | 3,100 0.008% | $49.78 | $154,318 | +0.87% | ||
| 2024-10-14 | Sale | See remarks | 3,100 0.008% | $50.09 | $155,268 | +0.80% | ||
| 2024-10-11 | Sale | See remarks | 3,100 0.008% | $50.19 | $155,594 | +0.92% | ||
| 2024-10-10 | Sale | See remarks | 3,105 0.0078% | $48.82 | $151,596 | +1.52% | ||
| 2024-10-08 | Sale | See remarks | 3,100 0.0077% | $48.26 | $149,612 | +2.58% | ||
| 2024-10-04 | Sale | See remarks | 3,100 0.0077% | $48.01 | $148,824 | +3.21% | ||
| 2024-10-01 | Sale | See remarks | 15,000 0.0375% | $48.45 | $726,730 | +6.53% | ||
| 2024-09-30 | Sale | See remarks | 3,100 0.0078% | $49.02 | $151,947 | +1.56% | ||
| 2024-09-26 | Sale | See remarks | 3,105 0.0075% | $49.29 | $153,054 | +0.92% | ||
| 2024-09-23 | Sale | See remarks | 3,100 0.008% | $52.67 | $163,263 | -2.97% | ||
| 2024-09-20 | Sale | See remarks | 3,100 0.0078% | $53.19 | $164,901 | -5.41% | ||
| 2024-09-17 | Sale | See remarks | 3,100 0.0078% | $56.11 | $173,944 | -10.47% | ||
| 2024-08-05 | Sale | See remarks | 9,000 0.0222% | $39.25 | $353,291 | +27.17% | ||
| 2024-07-01 | Sale | Chief Financial Officer | 18,402 0.0485% | $58.68 | $1.08M | 0.00% |
Insider Historical Profitability
| Kurtz Ronald M MD | President & CEO | 764610 1.9268% | $50.90 | 2 | 4 | <0.0001% |
| Weinberg Eric | Chief Commercial Officer | 299978 0.7559% | $50.90 | 5 | 6 | <0.0001% |
| Goldshleger Ilya | See remarks | 42246 0.1065% | $50.90 | 1 | 29 | <0.0001% |
| Tammenoms Bakker Juliet | director | 34840 0.0878% | $50.90 | 5 | 10 | +44.34% |
| Andrews Julie | director | 30287 0.0763% | $50.90 | 1 | 1 | <0.0001% |
Institutional Investor Ownership
| RA Capital Management, L.P. | $177.58M | 8.84 | 3.44M | +1.13% | +$1.99M | 0.18 | |
| BlackRock | $108.81M | 5.42 | 2.11M | +1.59% | +$1.71M | <0.01 | |
| Artisan Partners | $97.78M | 4.87 | 1.9M | -20.87% | -$25.79M | 0.14 | |
| Lord Abbett | $91.42M | 4.55 | 1.77M | -10.35% | -$10.55M | 0.32 | |
| The Vanguard Group | $78.63M | 3.91 | 1.52M | +2.73% | +$2.09M | <0.01 |